Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non–small‐cell lung cancer (<scp>NEJ056</scp>)

2024-9-15

Identification of <scp>TPI1</scp> As a potential therapeutic target in pancreatic cancer with dependency of <scp><i>TP53</i></scp> mutation using multi‐omics analysis

2024-9-11

Chromosome aberrations cause tumorigenesis through chromosomal rearrangements in a hepatocarcinogenesis rat model

2024-9-8

Rafoxanide negatively modulates <scp>STAT3</scp> and <scp>NF</scp>‐<scp>κB</scp> activity and inflammation‐associated colon tumorigenesis

2024-9-6

A novel histopathological feature of spatial tumor–stroma distribution predicts lung squamous cell carcinoma prognosis

2024-9-3

Crosstalk between GBP2 and M2 macrophage promotes the ccRCC progression

2024-9-2

High‐quality expert annotations enhance artificial intelligence model accuracy for osteosarcoma X‐ray diagnosis

2024-9-2

Prostate cancer treatment recommendation study based on machine learning and <scp>SHAP</scp> interpreter

2024-9-2

Issue Information

2024-9-1

In this issue

2024-9-1

<scp>RETRACTION</scp>: <scp>STUB1</scp> Suppresseses Tumorigenesis and Chemoresistance Through Antagonizing <scp>YAP1</scp> Signaling

2024-8-29

Phosphoribosyl pyrophosphate amidotransferase: Novel biomarker and therapeutic target for nasopharyngeal carcinoma

2024-8-28

Plasma ofCS‐modified CD44 predicts the survival of patients with lung cancer

2024-8-27

CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies

2024-8-25

A novel index combining fecal immunochemical test, <scp>DNA</scp> test, and age improves detection of advanced colorectal adenoma

2024-8-24

Genomic structural variants analysis in leukemia by a novel cytogenetic technique: Optical genome mapping

2024-8-24

Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in <i>BRAF</i>^V600E colorectal cancer

2024-8-22

Unlocking Japan's cervical cancer prevention deadlock

2024-8-22

Cervical mucus can be used for metabolite screening in cervical cancer

2024-8-22

<scp>RETRACTION</scp>: Exosomal <scp>miR</scp>‐106a‐5p Accelerates the Progression of Nasopharyngeal Carcinoma Through <scp>FBXW7</scp>‐Mediated <scp>TRIM24</scp> Degradation

2024-8-21

Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors

2024-8-21

<scp>ACTN4</scp> is associated with the malignant potential of thymic epithelial tumors through the β‐catenin/Slug pathway

2024-8-21

Correction to “<scp>ELF3</scp>‐<scp>AS1</scp> contributes to gastric cancer progression by binding to <scp>hnRNPK</scp> and induces thrombocytosis in peripheral blood”SongS, HeX, WangJ, et al. ELF3‐AS1 contributes to gastric cancer progression by binding to hnRNPK and induces thrombocytosis in peripheral blood. Cancer Sci.2021; 112: 4553–4569. 10.1111/cas.15104

2024-8-19

Chromatin lysine acylation: On the path to chromatin homeostasis and genome integrity

2024-8-18

A highly sensitive reporter system to monitor endogenous <scp>YAP1</scp>/<scp>TAZ</scp> activity and its application in various human cells

2024-8-18

<i>Fusobacterium nucleatum</i>, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis

2024-8-14

Accurate predictors of immune checkpoint inhibitors in patients with gallbladder cancer

2024-8-14

Mechanism research of non‐coding RNA in immune checkpoint inhibitors therapy

2024-8-13

<scp>CLG</scp> promotes <scp>mTOR</scp>/<scp>ULK1</scp> pathway‐mediated autophagy to inhibit <scp>OS</scp> development by inhibiting <scp>TRAF6</scp>‐mediated <scp>FLT3</scp> ubiquitination

2024-8-9

Overcoming immunotherapy resistance and inducing abscopal effects with boron neutron <scp>immunotherapy</scp> (B‐<scp>NIT</scp>)

2024-8-9

A multicenter study on deep learning for glioblastoma auto‐segmentation with prior knowledge in multimodal imaging

2024-8-9

Correction to: <scp>AC016405</scp>.3, a novel long noncoding <scp>RNA</scp>, acts as a tumor suppressor through modulation of <scp>TET2</scp> by <scp>microRNA</scp>‐19a‐5p sponging in glioblastoma

2024-8-9

Newly developed humanized anti‐<scp>CKAP4</scp> antibody suppresses pancreatic cancer growth by inhibiting <scp>DKK1</scp>‐<scp>CKAP4</scp> signaling

2024-8-8

Delta‐6 desaturase <scp>FADS2</scp> is a tumor‐promoting factor in cholangiocarcinoma

2024-8-7

N‐acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression

2024-8-6

Concerning trends and potential issues in osteosarcoma research publication

2024-8-6

Unveiling hierarchy and spatial distribution of O⁶‐methylguanine‐DNA methyltransferase promoter methylation in World Health Organization grade 2–3 gliomas

2024-8-5

<scp>RETRACTION</scp>: Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor‐<scp>κB</scp>‐Induced Matrix Metalloproteinase 2 Expression

2024-8-5

Issue Information

2024-8-1

In this issue

2024-8-1

Tumor‐derived mitochondrial formyl peptides suppress tumor immunity through modification of the tumor microenvironment

2024-7-31

Multiplex plasma protein assays as a diagnostic tool for lung cancer

2024-7-30

<scp>MGMT</scp> protein expression is a reliable predictive biomarker for temozolomide‐containing chemotherapy in osteosarcoma

2024-7-30

Correction to “<scp>P68 RNA</scp> helicase promotes invasion of glioma cells through negatively regulating <scp>DUSP5</scp>”

2024-7-29

Blocking <scp>CXCR4</scp>–<scp>CARM1</scp>–<scp>YAP</scp> axis overcomes osteosarcoma doxorubicin resistance by suppressing aerobic glycolysis

2024-7-28

The molecular mechanism underlying KRAS regulation on STK31 expression in pancreatic ductal adenocarcinoma

2024-7-25

Correction to inhibition of <scp>microRNA</scp> let‐7b expression by <scp>KDM2B</scp> promotes cancer progression by targeting <scp>EZH2</scp> in ovarian cancer

2024-7-23

Spatial omics technologies for understanding molecular status associated with cancer progression

2024-7-23